Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers
Clinical trial NCT04739917 · UNKNOWN
Trial details
- NCT number
- NCT04739917
- Sponsor
- Malaria Vaccine and Drug Development Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2022-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.